DNLI: Denali Therapeutics Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 4,094.57
Enterprise Value ($M) 4,003.93
Book Value ($M) 1,318.49
Book Value / Share 9.16
Price / Book 3.11
NCAV ($M) 733.32
NCAV / Share 5.10
Price / NCAV 5.58

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.35
Return on Equity (ROE) -0.38

Liquidity (mrq)
Quick Ratio 9.98
Current Ratio 9.98

Balance Sheet (mrq) ($M)
Current Assets 868.84
Assets 1,454.01
Liabilities 135.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
6 days ago 13G/A Fmr Llc 7.08 41.02
6 days ago 13G Capital Research Global Investors 5.50
11-08 13G/A Wellington Management Group Llp 7.49 47.46
11-08 13G/A BlackRock, Inc. 9.60 0.00
11-07 13G/A Biogen Inc. 4.97 -43.89
02-13 13G/A Bratton Douglas K 4.20 -17.85
02-13 13G/A Vanguard Group Inc 7.84 8.92
01-30 13G/A Temasek Holdings (Private) Ltd 4.90 0.00
01-30 13G/A Baillie Gifford & Co 10.32 -5.68

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 114,909 913,539 12.58
2024-11-14 88,695 524,963 16.90
2024-11-13 109,069 1,447,828 7.53
2024-11-12 95,355 623,160 15.30

(click for more detail)

Similar Companies
CTMX – CytomX Therapeutics, Inc. CYTK – Cytokinetics, Incorporated
DAWN – Day One Biopharmaceuticals, Inc. DSGN – Design Therapeutics, Inc.
DVAX – Dynavax Technologies Corporation


Financial data and stock pages provided by
Fintel.io